John Ouren

John Ouren is an Operating Partner at STG. As a part of his Operating Partner role, John was most recently Executive Chairman of Simmons Research and led the creation of the MRI-Simmons joint venture between GfK and Simmons. Prior to his role at Simmons, John was the CEO of AlphaImpactRx where he grew EBITDA over 60% over his tenure. John successfully led the company to its sale to IMS Health in 2016 and remained with the company to achieve a successful transition.